Brief: Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22
Dec 18 (Reuters) - Eli Lilly and Co LLY.N :
* LILLY EXTENDS TENDER OFFER TO ACQUIRE POINT BIOPHARMA TO
DEC.
22, 2023
Source text for Eikon: ID:nPn4pzhfba
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower